@FiercePharma: Drugmakers in India trapped between price caps and shortage rules. More | Follow @FiercePharma
@TracyStaton: Here's @JohnCFierce's take on the Vertex VX-809/Kalydeco PhIII, including interview with CEO Jeff Leiden. Story | Follow @TracyStaton
@EricPFierce: Abbott, in Russia since 1978, knows the game, buys Veropharm to establish local production credentials. News | Follow @EricPFierce
@CarlyHFierce: Have YOU checked out the list of 15 Highest-Paid Biopharma CEOs of 2013? Report | Follow @CarlyHFierce
> A GlaxoSmithKline ($GSK) vaccine plant in Canada has been sent a warning letter from the FDA for manufacturing problems that could lead to microbial contamination. Warning Letter
> Forest Laboratories ($FRX) says that its antidepressant Viibryd performed significantly better than a placebo for generalized anxiety disorder, which could be boon for Actavis ($ACT), which is buying Forest. Story
> Merck ($MRK) has named Michael J. Holston to succeed Bruce N. Kuhlik as general counsel when he retires July 1, 2015. Release
> Analysts at BNP Paribas said in a note that if Pfizer ($PFE) would raise its £70 billion bid for AstraZeneca ($AZN) to £75 billion ($127.7 billion), they think it could pull off a deal to buy the U.K. company. Blog Post
> Jiangsu Hengrui Medicine, among China's biggest privately-owned drugmakers, says the FDA approved its oxaliplatin to treat colon and rectal cancer. Report
Medical Device News
@FierceMedDev: New fibroid-removal device provides less invasive alternative. News | Follow @FierceMedDev
@StacyALawrence: Apple, Google stalk wearable med tech with glucose monitoring up first. More | Follow @StacyALawrence
@MichaelGFierce: Sinus drug delivery startup Intersect ENT files for $80 million IPO. Story via Silicon Valley Business Journal | Follow @MichaelGFierce
@EmilyWFierce: California's high court rules that large retailers don't need to keep external defibrillators on hand for customers. Story via LA Times | Follow @EmilyWFierce
> Philips launches image-guided neurology surgical tech in Europe. More
> Medtronic rebuffed by SCOTUS in pain-pump lawsuit. Story
Biotech News
@FierceBiotech: Merck targets Alzheimer's in $526M collaboration on new cognitive treatment. More | Follow @FierceBiotech
@JohnCFierce: Biotech star Bosley takes the helm at Editas. Item | Follow @JohnCFierce
@DamianFierce: Shire's Ornskov isn't sweating AbbVie, keeping up with the World Cup. Story (The Danish Dynamite didn't qualify.) | Follow @DamianFierce
@EmilyMFierce: Mersana partners with EMD Serono to advance ADC platform. Article | Follow @EmilyMFierce
> Ohr touts visual acuity results as PhII eye study fails primary goal. Story
> Biotechs queue up for $269M in fresh IPOs amid a sector rebound. Article
> EY: R&D budgets soar as cash-laden biotechs spend big on research. More
Biotech Research News
> UC San Diego to lead $2M statewide brain research project. More
> NIH awards U. of Buffalo $4.4M to repurpose old antibiotics. Story
> Novartis MS drug Gilenya could relieve painful side effect of chemo. Article
> UPenn team IDs potential target for treating Type 1 diabetes. News
> Mersana partners with EMD Serono to advance ADC platform. Report
Pharma Manufacturing News
> Carlyle buys Japanese contract manufacturer Sunsho. More
> West Pharmacuetical readies its first India injectables packaging plant. Article
> Abbott gets local production cred with deal to buy Russia's Veropharm. News
> Drugmakers in India trapped between price caps and shortage rules. Report
> Aesica plant in Italy responds as China's track and trace rules come into play. Story
> GSK vaccine plant in Texas about a year away. Item
And Finally... Researchers say a man give Pfizer's ($PFE) rheumatoid arthritis drug Xeljanz to treat his plaque psoriasis and alopecia universalis, a rare auto-immune disease which causes loss of body hair, grew a full head of hair in 8 months of treatment. Story